Beckman Coulter Life Sciences and Illumina have collaborated to introduce a new automated solution for oncology research. The Illumina TruSight™ Oncology 500 DNA/RNA assay on the Biomek NGeniuS System offers faster results with reduced manual touchpoints. The application allows for comprehensive genomic profiling of tumor samples, detecting various cancer biomarkers. Library preparation can be completed in less than three days, accommodating high-quality and low-quality samples in a single batch. The system aims to accelerate research and reduce hands-on time, making cutting-edge research more accessible and sustainable. This collaboration continues to enable genomics as a critical tool for clinical research in oncology.
Source link
Beckman Coulter and Illumina Accelerate Oncology Research
